THE INFLUENCE OF OLIGOMERIC PROTEINS AND THEIR IMMUNE COMPLEXES ON THE PHENOTYPE OF MACROPHAGES

Asta Lučiūnaitė1, Indrė Dalgėdienė1, Aurelija Žvirblienė1

1 VU Institute of Biotechnology, Vilnius, Lithuania

BACKGROUND: Macrophages, cells of the immune system, play a key role in defending organism from intracellular and extracellular pathogens [1]. In certain pathologies, chronic inflammation can be a result of the immune system disorders. As a consequence, various tissues can be damaged, for example, the neurodegenerative process can occur in the central nervous system. One of these pathologies is Alzheimer's disease (AD). This disease is caused by $\beta$-amyloids (A$\beta$), especially A$\beta$1-42 oligomers, which are detected in the brain tissue of the AD patients [2, 3]. Immunotherapy was applied in order to decrease the effects of A$\beta$. However, some clinical trials were discontinued due to the side effects such as meningoencephalitis [4]. The aim of this work is to investigate the influence of A$\beta$1-42 oligomers and their immune complexes on macrophage phenotype.

METHODS: The study model is macrophage cell line J774, originated from BALB/c mice. The investigation of various macrophage activation states was based on the detection of markers of classically activated M1 and alternatively activated M2 macrophage populations. The variations in the levels of cellular markers – M1 markers CD86, IL-12/IL-23, TNF-$\alpha$; M2 markers CD206, IL-10, TGF-$\beta$1; phagocytosis marker CD68; macrophage and cell activation marker F4/80 – were investigated by flow cytometry and enzyme-linked immunosorbent assay.

RESULTS: Treatment of J774 cells with A$\beta$1-42 oligomers and their immune complexes induced an increase in the expression of cell activation markers CD68, CD86, F4/80, IL-12/IL-23 and TNF-$\alpha$. However, there was no change in the expression of M2 markers.

CONCLUSION: Based on our research, activated mouse macrophages J774 show changes in CD68, CD86, F4/80, IL-12/IL-23 and TNF-$\alpha$ expression. This suggests that activation of macrophages with A$\beta$1-42 oligomers and their immune complexes can lead to the inflammatory phenotype M1.

Acknowledgments: This research was funded by a grant (No. LIG-04/2012) from the Research Council of Lithuania.


[1] D.M. Mosser, J.P. Edwards, Exploring the full spectrum of macrophage activation, Nature reviews. Immunology 8, 958-969 (2008).

[2] H. Braak, E. Braak, J. Bohl, Staging of Alzheimer-related cortical destruction, European neurology 33, 403-408 (1993).

[3] K.A. Jellinger, C. Bancher, Neuropathology of Alzheimer's disease: a critical update, Journal of neural transmission. Supplementum 54, 77-95 (1998).

[4] J.M. Orgogozo, S. Gilman, J.F. Dartigues, B. Laurent, M. Puel, L.C. Kirby, P. Jouanny, B. Dubois, L. Eisner, S. Flitman, B.F. Michel, M. Boada, A. Frank, C. Hock, Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization, Neurology 61, 46-54 (2003).